Your session is about to expire
← Back to Search
Radical Prostatectomy for Prostate Cancer
Study Summary
This trial is testing aspirin, rintatolimod, and interferon-alpha 2b to treat prostate cancer before surgery. The goal is to see if they can keep the cancer from coming back and slowing tumor growth.
- Prostate Cancer
- Prostate Adenocarcinoma
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 2 trial • 86 Patients • NCT03279250Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are new patients welcome to enroll in this clinical trial?
"The clinical trial is currently seeking enrolment from patients. The first posting was on 29th November 2019 with the latest update happening on 12th October 2020."
What are the usual motivations for a Radical Prostatectomy?
"While Radical Prostatectomy is commonly used as a pain management strategy, this surgical intervention can also be used to ameliorate other conditions such as myocardial infarction, catarrh, hepatitis c virus (hcv) infection."
How many study volunteers are participating in this research?
"Yes, this is an ongoing trial that was first posted on 29 November 2019. The listing was last updated 12 October 2022 and the study seeks 45 patients at a single site."
Is there a heightened risk for complications with Radical Prostatectomy?
"There is some data supporting Radical Prostatectomy's safety, but none yet for efficacy. It received a score of 2."
Share this study with friends
Copy Link
Messenger